Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CD44 | P16070 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22202259 | 0.75 | PDK2 (0.41) | CYP1A2TSHRACHEPDK2 | |
| SCHEMBL12533336 | 0.68 | PDE7A (0.33) | CYP2A6CYP1A2CD44ALDH1A1CA1 | |
| SCHEMBL22044198 | 0.64 | PDK2 (0.52) | ALDH1A1CA1CA2CA7CA9 | |
| SCHEMBL24858844 | 0.64 | CA1 (0.39) | CYP2A6CYP1A2CD44ALDH1A1CA1 | |
| SCHEMBL24701902 | 0.64 | CYP1A2 (0.35) | CYP2A6CYP1A2CD44ALDH1A1CA1 | |
| SCHEMBL24701663 | 0.64 | CYP1A2 (0.35) | CYP2A6CYP1A2CD44ALDH1A1CA1 | |
| SCHEMBL22973341 | 0.62 | PDK2 (0.36) | CYP2A6CYP1A2CD44ALDH1A1CA1 | |
| SCHEMBL23449322 | 0.62 | CD44 (0.33) | CYP2A6CYP1A2CD44ALDH1A1CA1 | |
| SCHEMBL25629793 | 0.62 | ACHE (0.38) | CYP2A6CYP1A2CD44ALDH1A1CA1 | |
| SCHEMBL24701724 | 0.60 | CYP1A2 (0.38) | CYP2A6CYP1A2ALDH1A1ACHEPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220393115-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220393115-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | LEF1, L1CAM, PIEZO1 | CYP2A6 3670/4885CYP1A2 1171/4885CD44 2443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.